Literature DB >> 35075457

Mucociliary Transport Deficiency and Disease Progression in Syrian Hamsters with SARS-CoV-2 Infection.

Qian Li, Kadambari Vijaykumar, Scott E Philips, Shah S Hussain, Van N Huynh, Courtney M Fernandez-Petty, Jacelyn E Peabody Lever, Jeremy B Foote, Janna Ren, Javier Campos-Gómez, Farah Abou Daya, Nathaniel W Hubbs, Harrison Kim, Ezinwanne Onuoha, Evan R Boitet, Lianwu Fu, Hui Min Leung, Linhui Yu, Thomas W Detchemendy, Levi T Schaefers, Jennifer L Tipper, Lloyd J Edwards, Sixto M Leal, Kevin S Harrod, Guillermo J Tearney, Steven M Rowe.   

Abstract

Substantial clinical evidence supports the notion that ciliary function in the airways plays an important role in COVID-19 pathogenesis. Although ciliary damage has been observed in both in vitro and in vivo models, consequent impaired mucociliary transport (MCT) remains unknown for the intact MCT apparatus from an in vivo model of disease. Using golden Syrian hamsters, a common animal model that recapitulates human COVID-19, we quantitatively followed the time course of physiological, virological, and pathological changes upon SARS-CoV-2 infection, as well as the deficiency of the MCT apparatus using micro-optical coherence tomography, a novel method to visualize and simultaneously quantitate multiple aspects of the functional microanatomy of intact airways. Corresponding to progressive weight loss up to 7 days post-infection (dpi), viral detection and histopathological analysis in both the trachea and lung revealed steadily descending infection from the upper airways, as the main target of viral invasion, to lower airways and parenchymal lung, which are likely injured through indirect mechanisms. SARS-CoV-2 infection caused a 67% decrease in MCT rate as early as 2 dpi, largely due to diminished motile ciliation coverage, but not airway surface liquid depth, periciliary liquid depth, or cilia beat frequency of residual motile cilia. Further analysis indicated that the fewer motile cilia combined with abnormal ciliary motion of residual cilia contributed to the delayed MCT. The time course of physiological, virological, and pathological progression suggest that functional deficits of the MCT apparatus predispose to COVID-19 pathogenesis by extending viral retention and may be a risk factor for secondary infection. As a consequence, therapies directed towards the MCT apparatus deserve further investigation as a treatment modality.

Entities:  

Year:  2022        PMID: 35075457      PMCID: PMC8786228          DOI: 10.1101/2022.01.16.476016

Source DB:  PubMed          Journal:  bioRxiv


  69 in total

1.  Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies.

Authors:  Hui Min Leung; Susan E Birket; Chulho Hyun; Timothy N Ford; Dongyao Cui; George M Solomon; Ren-Jay Shei; Adegboyega Timothy Adewale; Andrew R Lenzie; Courtney M Fernandez-Petty; Hui Zheng; Justin H Palermo; Do-Yeon Cho; Bradford A Woodworth; Lael M Yonker; Bryan P Hurley; Steven M Rowe; Guillermo J Tearney
Journal:  Sci Transl Med       Date:  2019-08-07       Impact factor: 17.956

2.  Gross examination report of a COVID-19 death autopsy.

Authors:  Q Liu; R S Wang; G Q Qu; Y Y Wang; P Liu; Y Z Zhu; G Fei; L Ren; Y W Zhou; L Liu
Journal:  Fa Yi Xue Za Zhi       Date:  2020-02-25

3.  Multiorgan and Renal Tropism of SARS-CoV-2.

Authors:  Victor G Puelles; Marc Lütgehetmann; Maja T Lindenmeyer; Jan P Sperhake; Milagros N Wong; Lena Allweiss; Silvia Chilla; Axel Heinemann; Nicola Wanner; Shuya Liu; Fabian Braun; Shun Lu; Susanne Pfefferle; Ann S Schröder; Carolin Edler; Oliver Gross; Markus Glatzel; Dominic Wichmann; Thorsten Wiech; Stefan Kluge; Klaus Pueschel; Martin Aepfelbacher; Tobias B Huber
Journal:  N Engl J Med       Date:  2020-05-13       Impact factor: 91.245

4.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

5.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

6.  Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.

Authors:  Lisa H Tostanoski; Frank Wegmann; Amanda J Martinot; Carolin Loos; Katherine McMahan; Noe B Mercado; Jingyou Yu; Chi N Chan; Stephen Bondoc; Carly E Starke; Michael Nekorchuk; Kathleen Busman-Sahay; Cesar Piedra-Mora; Linda M Wrijil; Sarah Ducat; Jerome Custers; Caroline Atyeo; Stephanie Fischinger; John S Burke; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Esther A Bondzie; Gabriel Dagotto; Makda S Gebre; Catherine Jacob-Dolan; Zijin Lin; Shant H Mahrokhian; Felix Nampanya; Ramya Nityanandam; Laurent Pessaint; Maciel Porto; Vaneesha Ali; Dalia Benetiene; Komlan Tevi; Hanne Andersen; Mark G Lewis; Aaron G Schmidt; Douglas A Lauffenburger; Galit Alter; Jacob D Estes; Hanneke Schuitemaker; Roland Zahn; Dan H Barouch
Journal:  Nat Med       Date:  2020-09-03       Impact factor: 53.440

7.  Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.

Authors:  Jasper Fuk-Woo Chan; Anna Jinxia Zhang; Shuofeng Yuan; Vincent Kwok-Man Poon; Chris Chung-Sing Chan; Andrew Chak-Yiu Lee; Wan-Mui Chan; Zhimeng Fan; Hoi-Wah Tsoi; Lei Wen; Ronghui Liang; Jianli Cao; Yanxia Chen; Kaiming Tang; Cuiting Luo; Jian-Piao Cai; Kin-Hang Kok; Hin Chu; Kwok-Hung Chan; Siddharth Sridhar; Zhiwei Chen; Honglin Chen; Kelvin Kai-Wang To; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

8.  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.

Authors:  Michael Letko; Andrea Marzi; Vincent Munster
Journal:  Nat Microbiol       Date:  2020-02-24       Impact factor: 17.745

9.  Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.

Authors:  M Alejandra Tortorici; Martina Beltramello; Florian A Lempp; Dora Pinto; Ha V Dang; Laura E Rosen; Matthew McCallum; John Bowen; Andrea Minola; Stefano Jaconi; Fabrizia Zatta; Anna De Marco; Barbara Guarino; Siro Bianchi; Elvin J Lauron; Heather Tucker; Jiayi Zhou; Alessia Peter; Colin Havenar-Daughton; Jason A Wojcechowskyj; James Brett Case; Rita E Chen; Hannah Kaiser; Martin Montiel-Ruiz; Marcel Meury; Nadine Czudnochowski; Roberto Spreafico; Josh Dillen; Cindy Ng; Nicole Sprugasci; Katja Culap; Fabio Benigni; Rana Abdelnabi; Shi-Yan Caroline Foo; Michael A Schmid; Elisabetta Cameroni; Agostino Riva; Arianna Gabrieli; Massimo Galli; Matteo S Pizzuto; Johan Neyts; Michael S Diamond; Herbert W Virgin; Gyorgy Snell; Davide Corti; Katja Fink; David Veesler
Journal:  Science       Date:  2020-09-24       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.